# Christina Lopes

> Christina Lopes is the CEO and co-founder of The One Health Company, the maker of FidoCure, the first human-grade precision cancer treatment platform for dogs. A former managing director at the $30B private equity firm Cerberus Capital, she left high finance to build a company that sequences canine tumors, matches them with targeted therapies, and feeds the resulting clinico-genomic data back into the fight against human cancer. Born in Brazil and raised across the US and Ireland, she has been named a World Economic Forum Young Global Leader and an Inc. Top 100 Female Founder.

- **Role:** CEO & Co-Founder at The One Health Company (FidoCure)
- **Organizations:** The One Health Company, FidoCure, Cerberus Capital Management, International Planned Parenthood Federation, UN Commission on the Status of Women
- **From:** Brazil
- **Nationality:** Brazilian-American
- **Education:** B.A., University of Massachusetts, M.A., International and Political Affairs, Columbia University, Doctoral coursework in Ethics, Princeton University
- **Known for:** Co-founded and leads FidoCure, the first human-grade precision cancer treatment platform for dogs, Expanded FidoCure into more than 1,350 veterinary clinics and treated over 5,000 dogs with cancer, Named a Young Global Leader by the World Economic Forum at Davos

## Career timeline

- **pre-2016** — Managing Director at Cerberus Capital, a private equity firm with ~$30B in assets under management; worked in emerging-markets finance
- **pre-2016** — Advisory Board Director for International Planned Parenthood (Western Hemisphere) and advisor to the UN Commission on the Status of Women
- **2016** — Co-founded The One Health Company in Philadelphia with Ben Lewis
- **2019** — Raised $5M seed round led by Andreessen Horowitz's Bio fund, with Lerer Hippeau and Y Combinator
- **2020** — Raised $10M Series A led by Polaris Partners and Borealis Ventures; FidoCure available in all 50 US states
- **2024** — Showcased what the company calls the world's only portfolio of canine cancer drugs at the Animal Health Summit

## Achievements

- Co-founded and leads FidoCure, the first human-grade precision cancer treatment platform for dogs
- Expanded FidoCure into more than 1,350 veterinary clinics and treated over 5,000 dogs with cancer
- Named a Young Global Leader by the World Economic Forum at Davos
- Named to Inc. Magazine's Top 100 Female Founders
- Raised more than $16M for One Health Company from investors including a16z, Polaris Partners, Lerer Hippeau, and Y Combinator
- Built one of the largest clinico-genomic datasets in comparative oncology

## Latest updates

- **2024-09** — Presented what FidoCure describes as the world's only portfolio of canine cancer drugs at the 2024 Animal Health Summit.

## Links

- Website: https://fidocure.com
- LinkedIn: http://www.linkedin.com/in/christina-lopes-8679455
- Twitter/X: https://twitter.com/fidocure
- Facebook: https://facebook.com/FidoCure/

---

Profile page: https://yespress.io/christina-lopes
Published by YesPress — https://yespress.io
Last updated: 2026-06-14